WHO grants emergency use of Johnson and Johnson vaccine

The World Health Organization granted an emergency use listing for the coronavirus vaccine made by Johnson & Johnson, meaning the one-dose shot can be used as part of the international COVAX effort to distribute vaccines globally, including to developing countries with no supplies.

In a statement on Friday, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union. The U.S. Food and Drug Administration granted the J&J vaccine an emergency authorization last month.

A massive study that spanned three continents found the J&J vaccine was 85% effective in protecting against severe illness, hospitalization and death. That protection remained strong even in countries such as South Africa with variants.

The U.N.-backed COVAX effort previously announced it had an initial agreement with J&J to provide 500 million doses, but it’s not legally binding.

___

Source: Associated Press

When you purchase a book below it supports the Number #1 Black Christian Newspaper BLACK CHRISTIAN NEWS NETWORK ONE (BCNN1.com) and it also allows us to spread the Gospel around the world.